Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I, Randomised, Double-blind, Sequential, placebo-controlled trial to evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple-dose Suvorexant in Healthy Men

Trial Profile

A Phase I, Randomised, Double-blind, Sequential, placebo-controlled trial to evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple-dose Suvorexant in Healthy Men

Completed
Phase of Trial: Phase I

Latest Information Update: 07 May 2018

At a glance

  • Drugs Suvorexant (Primary)
  • Indications Insomnia
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 07 May 2018 New trial record
    • 28 Apr 2018 Results published in the Clinical Drug Investigation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top